In this episode, Dr Dhruv discusses TED patient identification and management based on the published American Thyroid Association (ATA)/European Thyroid Association (ETA) consensus statement, including the use of TEPEZZA® (teprotumumab-trbw) for treatment regardless of disease activity or duration.&nbsp;

Consensus in Action: Endocrinologists and Management of Patients with Thyroid Eye Disease (TED)

Mary Ann Liebert, Inc. a Sage company, is a leading company in the Scientific, Technical, and Medical knowledge and information industry. We are known for authoritative international publications in cutting-edge basic and translational biomedical research, with expanding scope in engineering, business, environment, and legal publications. These publications play an active and important role in advancing critical research and facilitating collaboration throughout the world in academia, industry, and government, and are also highly respected resources for legislators, policy makers, and educators.

Share

MAL Podcasts

Consensus in Action: Endocrinologists and Management of Patients with Thyroid Eye Disease (TED)